L’AstraZeneca archive NDA pour des Antiplatelet traitement Brilinta - mises à jour | Forex Analytics Blog
« Le Rotork voit année l’profit à la fin supérieure des Mkt. Avis ; Directeur financier Bob Slater tonne Retire - mises à jour
Chacun pense que le Yuan est sous-estimé….À part la Chine »

L’AstraZeneca archive NDA pour des Antiplatelet traitement Brilinta - mises à jour

Pharmaceutical company AstraZeneca plc (AZN, AZN.L) said Thursday it has submitted has New Drug Application for ticagrelor to the U.S. Food and Drug Administration. Ticagrelor is oral year investigational antiplatelet treatment to reduce unfavourable major cardiac vents in patients with acute coronary syndrome. The proposed trade name for ticagrelor is Brilinta, which is yet to Be approved by the FDA.

More: continued here
Provided by Reiseshop
Blog Shop
Forex Analytics
Gold Ankauf
MS Net

(c)Autor: Forex Analytics Blog: earn money with Forex

convert this post to pdf.

This entry was posted on Sunday, November 22nd, 2009 at 12:11 pm and is filed under Currency News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.


3
Vote!
www.wikio.com

Leave a Reply